Difference between revisions of "Rheumatoid arthritis"

(Clinical Features)
(Clinical Features)
 
Line 4: Line 4:
 
==Clinical Features==
 
==Clinical Features==
 
[[File:Rheumatoid_nodules.jpg|thumb|Rheumatoid nodules on the extensor surfaces can develop in poorly controlled rheumatoid arthritis]]
 
[[File:Rheumatoid_nodules.jpg|thumb|Rheumatoid nodules on the extensor surfaces can develop in poorly controlled rheumatoid arthritis]]
[[File: swan neck deformity.jpg|thumb|Multiple [[swan neck deformities|swan neck deformity]] from poorly controlled rheumatoid arthritis]]
+
[[File: swan neck deformity.jpg|thumb|Multiple [[swan neck deformity|swan neck deformities]] from poorly controlled rheumatoid arthritis]]
 
*Morning stiffness
 
*Morning stiffness
 
*[[Polyarthritis]] of MCP and PIP joints
 
*[[Polyarthritis]] of MCP and PIP joints

Latest revision as of 01:46, 25 January 2021

Background

  • Rheumatoid arthritis is an autoimmune disease. It is an erosive polyarthritis that causes auto-antibodies direct against an individual's own joints and joint spaces.

Clinical Features

Rheumatoid nodules on the extensor surfaces can develop in poorly controlled rheumatoid arthritis
Multiple swan neck deformities from poorly controlled rheumatoid arthritis
  • Morning stiffness
  • Polyarthritis of MCP and PIP joints
    • Does NOT involve DIP joints
    • Wrists, elbows, shoulders, ankles, knees also commonly involved
  • Ulnar deviation at MTP joints
  • Swan neck deformity
  • Rheumatoid nodules
  • Most patients initially diagnosed in the early 50s
  • Common associated conditions in severe cases: pleuritis, interstitial lung disease, pericarditis, inflammatory eye disease

Differential Diagnosis

Polyarthritis

Algorithm for Polyarticular arthralgia

Oligoarthritis

Migratory Arthritis

Evaluation

  • Xray affected joints for erosions
  • Rheumatoid factor (positive in 60% to 70% of patients)
  • Anti-cyclic citrullinated peptide (CCP) antibodies (positive in about 70% of patients)
  • ANA
  • Consider arthrocentesis
    • WBC count typically 1,500-20,000

Management

  • NSAIDs
    • Symptomatic relief without slowing underlying disease
  • Glucocorticoids
    • Consider intraarticular injection if a single joint is inflammed
    • Systemic steroids reserved for moderate-severe flairs
  • Opioids have a limited role
  • Disease-modifying antirheumatic drug (DMARD)
    • Can be started by primary care provider or rheumatologist after ER visit

Disposition

  • Discharge with referral to PCP or rheumatology

See Also

References